New clinical trials in Slovakia: 191 since Nov 2024

Name: New clinical trials in Slovakia
Creator: SpecStream
License: https://creativecommons.org/licenses/by/4.0/

The full list. New clinical trials with a site in Slovakia: 191 rows for $9.55, first posted on ClinicalTrials.gov from November 12, 2024 to November 9, 2026. The list gains about 5 rows a month. The new rows come each week by email, $19 a month.

Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (central contact, contact phone, contact email, sponsor class, condition groups (MeSH), interventions and 5 more), which open on your screen as soon as the payment clears and come by email. The weekly rows run until you cancel, from the link in each delivery. The rows on this page are a sample.

For agents and scripts: this list is ordered at https://specstream.ai/data/clinical-trials/country/slovakia, and every list with its row count and price is at https://specstream.ai/data/lists.json.

Updated November 4, 2026. Source: ClinicalTrials.gov API v2 (U.S. National Library of Medicine).

191 clinical studies with a site in Slovakia were first posted on ClinicalTrials.gov from November 12, 2024 to November 4, 2026; 129 have an industry sponsor and 117 are recruiting or about to. The newest, NCT07915219, was posted on November 4, 2026: A Study to Learn How Well People With Bronchiectasis Tolerate Continued Treatment With Verducatib After... (Boehringer Ingelheim).

The request: Every new clinical trial with a site in Slovakia, with the sponsor, phase, conditions and the listed contact. $10 of credit on sign-up, no card.

Get new trials like these Watch a sponsor

SpecStream is the live web data engine for teams and agents. It reads every new study on ClinicalTrials.gov each morning, and this page is that reading. Ask for the conditions, phases or countries you follow and each new trial arrives in your sheet, CRM, Slack or agent with the sponsor, the sites and the listed contact.

191New trials
129Industry sponsored
117Recruiting or not yet
November 4, 2026Latest posted

Newest trials

The newest 100 of 191, each linked to its record. The full list holds every one with the sponsor class, interventions, start date and the central contact as the record prints it.

First posted	NCT ID	Title	Sponsor	Phase	Status	Conditions	Enrollment	Countries	Source
November 4, 2026	NCT07915219	A Study to Learn How Well People With Bronchiectasis Tolerate Continued Treatment With Verducatib After Earlier Studies (AIRTIVITY®-ON)	Boehringer Ingelheim	Phase 3	Not yet recruiting	Bronchiectasis	1,500	Argentina, Austria, Belgium, Brazil, Bulgaria, Canada, Chile, China, Czechia...	clinicaltrials.gov
October 30, 2026	NCT07908108	Cross-cultural Adaptation and Validation of the Localised Scleroderma Quality of Life Instrument (LoSQI) in Juvenile Localised Scleroderma...	Istituto Giannina Gaslini	Observational	Active not recruiting	Scleroderma	272	Argentina, Brazil, China, Croatia, Denmark, Egypt, Germany, Greece, India...	clinicaltrials.gov
October 22, 2026	NCT07889089	Effects of Sprint and Eccentric Hamstring Training in Elite Youth Soccer Players	Comenius University	Not applicable	Not yet recruiting	Sprint Mechanical Output, Sprint Performance, Eccentric Hamstring Strength	15	Slovakia	clinicaltrials.gov
October 14, 2026	NCT07873034	Timing of VA-ECMO Support During or After Cardiac Surgery	National Institute of Cardiovascular Diseases, Slovakia	Observational	Completed	VA-ECMO for Postcardiotomy Cardiogenic Shock	128	Slovakia	clinicaltrials.gov
October 1, 2026	NCT07851025	Torvutatug Samrotecan Plus Bevacizumab as First-line Maintenance in Non-Homologous Recombination Deficiency (Non-HRD) Positive Advanced...	AstraZeneca	Phase 3	Recruiting	Epithelial Ovarian Cancer	950	Argentina, Australia, Brazil, Bulgaria, Canada, Chile, China, Colombia...	clinicaltrials.gov
September 29, 2026	NCT07845487	A Trial to Investigate PALI-2108 Versus Placebo in Participants With Moderately to Severely Active Ulcerative Colitis	Palisade Bio	Phase 2	Recruiting	Ulcerative Colitis (UC), Severe Ulcerative Colitis, Moderate Ulcerative Colitis	204	Canada, Czechia, France, Georgia, Hungary, Italy, Latvia, Poland, Romania...	clinicaltrials.gov
September 28, 2026	NCT07844122	Effects of Caffeine on Agility in Amateur Soccer Players	Comenius University	Not applicable	Completed	Healthy Adult Male	16	Slovakia	clinicaltrials.gov
September 21, 2026	NCT07832058	Necessity of Vascular Surgical Intervention in Pulseless Supracondylar Fractures in Children	University Hospital Hradec Kralove	Observational	Completed	Supracondylar Humerus Fracture, Vascular Trauma, Ischemia	190	Czechia, Slovakia	clinicaltrials.gov
September 14, 2026	NCT07817355	Dance-Based Exercise for Cancer-Related Fatigue in Breast Cancer Patients	Comenius University	Not applicable	Enrolling by invitation	Breast Neoplasms	104	Slovakia	clinicaltrials.gov
September 8, 2026	NCT07806266	EORTC Metastatic Breast Cancer Module Development	University of Leeds	Observational	Recruiting	Metastatic Beast Cancer	568	Belgium, Canada, France, Germany, India, Italy, Japan, Jordan, Netherlands...	clinicaltrials.gov
August 26, 2026	NCT07786506	Intermittent Theta-Burst Stimulation for Lower-Limb Spasticity and Pain in Multiple Sclerosis	Comenius University	Not applicable	Not yet recruiting	Multiple Sclerosis, Muscle Spasticity, Neuropathic Pain	40	Slovakia	clinicaltrials.gov
August 25, 2026	NCT07784270	A Study to Evaluate Effect of AZD6234 in Adult Participants With Type 2 Diabetes Mellitus and Obesity or Overweight	AstraZeneca	Phase 3	Recruiting	Obesity or Overweight, Diabetes Mellitus, Type 2	1,500	Argentina, Australia, Canada, Chile, China, Germany, Hungary, India, Japan...	clinicaltrials.gov
August 19, 2026	NCT07772518	Intracardiac Echocardiography-guided Versus Electroanatomical Mapping-guided Pulsed Field Ablation for Paroxysmal Atrial Fibrillation	Mitera Hospital	Not applicable	Recruiting	Paroxysmal Atrial Fibrillation (PAF)	292	Croatia, Czechia, Greece, Hungary, Italy, Poland, Slovakia, Slovenia	clinicaltrials.gov
August 12, 2026	NCT07761117	A Study to Investigate CV Outcomes With Elecoglipron Compared With Placebo in Adult Participants With HFpEF or HFmrEF	AstraZeneca	Phase 3	Recruiting	Heart Failure With Preserved Ejection Fraction (HFpEF), Heart Failure With Mildly Reduced Ejection Fraction (HFmrEF)	6,950	Argentina, Australia, Austria, Brazil, Bulgaria, Canada, China, Czechia...	clinicaltrials.gov
August 6, 2026	NCT07750249	The MIMIGA Study is a Randomized, Double-blind, Placebo-controlled Crossover Trial Evaluating the Safety and Efficacy of SCFA vs. Placebo....	University Hospital, Martin	Early phase 1	Enrolling by invitation	Primary IgA Nephropathy	120	Slovakia	clinicaltrials.gov
August 6, 2026	NCT07749183	A Photoplethysmography-Based Machine Learning Algorithm for Early Atrial Fibrillation Detection: A Prospective Validation Study	Seerlinq s. r. o.	Observational	Recruiting	Atrial Fibrillation (AF), Heart Failure	200	Slovakia	clinicaltrials.gov
July 28, 2026	NCT07731633	Acute Metabolic Response Versus Long-term Adaptation to a Vegan Diet	University Hospital, Martin	Not applicable	Completed	Vegan Diet, Body Composition, Quality of Life (QOL), Cardiometabolic Health	31	Slovakia	clinicaltrials.gov
July 9, 2026	NCT07691970	Rollover Study for Participants Who Have Completed a Previous Clinical Study With Anifrolumab (Saphnelo) and Clinically Benefited From...	AstraZeneca	Phase 3	Recruiting	Systemic Sclerosis Cutaneous Lupus E Myopathies Systemic Lupus Erythematosus	1,072	Argentina, Australia, Austria, Belgium, Brazil, Bulgaria, Canada, Chile, China...	clinicaltrials.gov
July 6, 2026	NCT07682818	Pharmacokinetics of Petrelintide in Participants With Impaired Hepatic Function	Zealand Pharma	Phase 1	Recruiting	Impaired Hepatic Function	36	Poland, Slovakia	clinicaltrials.gov
June 25, 2026	NCT07668388	A Research Study Comparing How Well Different Doses of the Medicine UBT251 Lower Blood Sugar in People With Type 2 Diabetes	Novo Nordisk A/S	Phase 2	Recruiting	Diabetes Mellitus, Type 2	300	Australia, Germany, Hungary, Poland, Romania, Slovakia, South Korea, Spain...	clinicaltrials.gov
June 23, 2026	NCT07662109	A Phase III Study to Investigate the Efficacy and Safety of the Combination of Elecoglipron and Dapagliflozin in Adults With Type 2...	AstraZeneca	Phase 3	Recruiting	Type 2 Diabetes Mellitus	2,000	Argentina, Brazil, China, Czechia, Denmark, Germany, Greece, Hungary, India...	clinicaltrials.gov
June 23, 2026	NCT07662044	A Phase III Study to Investigate the Efficacy and Safety of Elecoglipron Alone or in Combination With Dapagliflozin Compared With Placebo...	AstraZeneca	Phase 3	Recruiting	Type 2 Diabetes Mellitus	800	Argentina, China, Denmark, Greece, Hungary, Japan, Slovakia, South Africa...	clinicaltrials.gov
June 17, 2026	NCT07652294	Long-term Safety and Efficacy of Multiple Long-acting Antibodies Alone and in Combinations for IBD	Spyre Therapeutics, Inc.	Phase 2	Enrolling by invitation	Ulcerative Colitis, Inflammatory Bowel Diseases, Colitis, Colitis, Ulcerative	645	Argentina, Australia, Austria, Belgium, Brazil, Chile, Czechia, Georgia...	clinicaltrials.gov
June 5, 2026	NCT07630974	A Study of Ifinatamab Deruxtecan in Pediatric Participants With Relapsed or Refractory Solid Tumors (MK-9999-01D/LIGHTBEAM-U01)	Merck Sharp & Dohme LLC	Phase 1/2	Recruiting	Malignant Neoplasm	134	Australia, Belgium, Czechia, Denmark, France, Hungary, Israel, Netherlands...	clinicaltrials.gov
June 2, 2026	NCT07621809	Two Arm, Double-blind, Phase III Study Assessing Efficacy and Safety of Ianalumab Versus Placebo, in Participants With Sjögren's Disease...	Novartis Pharmaceuticals	Phase 3	Recruiting	Sjögren´s Disease	570	Australia, Austria, Brazil, Canada, China, Colombia, Czechia, France, Germany...	clinicaltrials.gov
May 29, 2026	NCT07614776	A Study to Evaluate Efficacy, Safety, and Immunogenicity With ABP 938 8 mg Versus EYLEA® HD (Aflibercept) in Participants With Neovascular...	Amgen	Phase 3	Recruiting	Neovascular Age-related Macular Degeneration, nAMD	304	Czechia, Hungary, Japan, Latvia, Lithuania, Poland, Slovakia, Spain, United...	clinicaltrials.gov
May 22, 2026	NCT07604415	Active Versus Passive Anal Sphincter Training in Patients With Fecal Incontinence	University Hospital, Martin	Not applicable	Recruiting	Fecal Incontinence	24	Slovakia	clinicaltrials.gov
May 14, 2026	NCT07587710	A Research Study Looking Into Blood Levels of the Medicine NNC0487-0111 in the Body and How Well it is Tolerated in People With Reduced...	Novo Nordisk A/S	Phase 1	Not yet recruiting	Overweight, Obesity	35	Slovakia	clinicaltrials.gov
May 11, 2026	NCT07577856	A Study of JNJ-78934804 in Participants With Moderately to Severely Active Ulcerative Colitis	Janssen Research & Development, LLC	Phase 3	Recruiting	Colitis, Ulcerative	644	Argentina, Australia, Austria, Belgium, Brazil, Bulgaria, Canada, China...	clinicaltrials.gov
May 11, 2026	NCT07577843	A Study of JNJ-78934804 in Participants With Moderately to Severely Active Crohn's Disease	Janssen Research & Development, LLC	Phase 3	Recruiting	Crohn Disease	460	Argentina, Australia, Austria, Belgium, Brazil, Canada, China, Czechia, France...	clinicaltrials.gov
May 4, 2026	NCT07564414	A Research Study to Look at How Two Different Doses of CagriSema and One Dose of Semaglutide Help People Living With Obesity With or...	Novo Nordisk A/S	Phase 3	Recruiting	Obesity, Type 2 Diabetes	2,500	Argentina, Australia, Austria, Belgium, Bulgaria, Canada, Czechia, France...	clinicaltrials.gov
May 1, 2026	NCT07560514	Assessment of Digital Technologies for Detection of Dental Caries	University Hospital, Martin	Not applicable	Recruiting	Dental Caries	100	Slovakia	clinicaltrials.gov
April 30, 2026	NCT07559890	Monopolar Basivertebral Nerve Ablation for Axial Low Back Pain	EPC Education s.r.o.	Not applicable	Recruiting	Chronic Back Pain, Basivertebral Nerve Ablation	100	Czechia, Slovakia, Sweden	clinicaltrials.gov
April 30, 2026	NCT07557901	A Study Comparing Infectious Complications After Transperineal Prostate Biopsy With or Without Antibiotic Prophylaxis	F.D. Roosevelt Teaching Hospital with Policlinic Banska Bystrica	Not applicable	Enrolling by invitation	Infectious Complications Following Prostate Biopsy, Prostate Cancer	300	Slovakia	clinicaltrials.gov
April 16, 2026	NCT07533175	AMAZE 2: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Type 2 Diabetes Lose...	Novo Nordisk A/S	Phase 3	Active not recruiting	Diabetes Mellitus, Overweight, Obesity	638	Argentina, Brazil, Croatia, Hungary, Italy, Mexico, Romania, Slovakia, South...	clinicaltrials.gov
April 13, 2026	NCT07522905	Virtual Buddy Movement Therapy for Psychomotor and Social Development in Pediatric Oncology Patients in Remission	Comenius University	Not applicable	Recruiting	Precursor Cell Lymphoblastic Leukemia-Lymphoma	24	Slovakia	clinicaltrials.gov
April 8, 2026	NCT07517263	An Open Label Extension (OLE) Study (Following Completion of CTQJ230A12301) to Evaluate Long-term Safety and Tolerability of Pelacarsen...	Novartis Pharmaceuticals	Phase 3	Active not recruiting	Cardiovascular Disease and Lipoprotein(a)	5,700	Argentina, Australia, Austria, Belgium, Brazil, Bulgaria, Canada, China...	clinicaltrials.gov
March 30, 2026	NCT07499232	A Study of Guselkumab Versus Risankizumab in Participants With Moderately to Severely Active Crohn's Disease	Janssen Research & Development, LLC	Phase 3	Recruiting	Crohn Disease	530	Austria, Belgium, Canada, China, Czechia, Denmark, France, Germany, Hungary...	clinicaltrials.gov
March 27, 2026	NCT07498179	Activation-Socialization Intervention Program for Seniors	Diana Ďuricová	Not applicable	Enrolling by invitation	Healthy	200	Slovakia	clinicaltrials.gov
March 24, 2026	NCT07491068	The Accuracy and Efficacy of Large Language Model Written Hospital Course Summaries	Pavol Jozef Safarik University	Not applicable	Not yet recruiting	Hospitalizations	786	Slovakia	clinicaltrials.gov
March 20, 2026	NCT07486674	Endoscopic and Cryoablation Denervation for Sacroiliac Joint Pain	EPC Education s.r.o.	Not applicable	Completed	Sacroiliac Joint Pain, Chronic Pain	51	Slovakia	clinicaltrials.gov
March 18, 2026	NCT07479004	Effect of Cream Paste Containg Pleuran on Selected Skin Dermatoses (Neonatal Pustulosis, Diaper Dermatitis, Perioral Dermatitis).	Pleuran, s.r.o.	Not applicable	Completed	Diaper Dermatitis, Perioral Dermatitis, Neonatal Pustulosis, Periorificial Dermatitis, Erythema	110	Slovakia	clinicaltrials.gov
March 17, 2026	NCT07476729	International Study for Treatment of Childhood Relapsed Precursor B-Cell ALL 2020 (IntReALL BCP 2020)	Charite University, Berlin, Germany	Phase 3	Recruiting	B-Cell Acute Lymphoblastic Leukaemia	750	Austria, Belgium, Czechia, Denmark, Finland, France, Germany, Hungary, Israel...	clinicaltrials.gov
March 16, 2026	NCT07474935	Targeting Real World Usage In Stroke Treatment	Phenox GmbH	Observational	Recruiting	Saccular and Fusiform Aneurysms, Pseudoaneurysm, Vascular Dissection, Perforation, Bifurcation Aneurysms, Stenosis...	5,000	France, Germany, Italy, Slovakia, Switzerland	clinicaltrials.gov
March 12, 2026	NCT07465809	Mental Health Resources and Employability in Healthcare	Comenius University	Not applicable	Completed	Burnout, Professional, Mental Health, Emotional Regulation, Occupational Stress	79	Slovakia	clinicaltrials.gov
March 10, 2026	NCT07460934	Effect of Pleuran on the Clinical Course of Patients With Chronic Rhinosinusitis	Pleuran, s.r.o.	Not applicable	Completed	Chronic Rhinosinusitis (CRS), Exacerbations, Respiratory Tract Infections (RTI), Antibiotic Prophylaxis	85	Czechia, Slovakia	clinicaltrials.gov
March 9, 2026	NCT07458737	Pelvic Floor Shear-Wave Elastography in Healthy and Pudendal Neuralgia Women	Comenius University	Observational	Completed	Pudendal Nerve, Healthy Women	94	Slovakia	clinicaltrials.gov
March 4, 2026	NCT07449936	COMO: A Phase 3 Randomized, Double-Masked Study Comparing the Efficacy of EYP-1901 Against Aflibercept in DME	EyePoint Pharmaceuticals, Inc.	Phase 3	Active not recruiting	Diabetic Macular Edema, DME, Diabetic Macular Edema (DME)	240	Germany, Israel, Poland, Slovakia, United States	clinicaltrials.gov
March 3, 2026	NCT07446556	Exercise Program in Women With Pudendal Neuralgia	Comenius University	Not applicable	Completed	Pudendal Neuralgia- Physiotherapy	83	Slovakia	clinicaltrials.gov
March 2, 2026	NCT07442838	Clinical Outcomes and Complications in Two-stage Breast Reconstruction Using Microtextured and Nanotextured Expanders	Comenius University	Observational	Active not recruiting	Breast Neoplasms	88	Slovakia	clinicaltrials.gov
February 27, 2026	NCT07439913	Predictive Factors for 10-year Biochemical Recurrence and Urinary Continence Following Robot-assisted Radical Prostatectomy for Prostate...	F.D. Roosevelt Teaching Hospital with Policlinic Banska Bystrica	Observational	Enrolling by invitation	Prostate Cancer (Adenocarcinoma)	120	Slovakia	clinicaltrials.gov
February 27, 2026	NCT07438496	A Study of Nipocalimab in Adults With Moderate to Severe Systemic Lupus Erythematosus	Janssen Research & Development, LLC	Phase 3	Recruiting	Lupus Erythematosus, Systemic	600	Argentina, Australia, Brazil, Bulgaria, China, Czechia, Denmark, Finland...	clinicaltrials.gov
February 17, 2026	NCT07415954	A Research Study Comparing How Well Different Doses of the Medicine NNC0662-0419 Lower Blood Sugar in People With Type 2 Diabetes	Novo Nordisk A/S	Phase 2	Recruiting	Diabetes Mellitus, Type 2	270	Croatia, Hungary, Japan, Poland, Portugal, Slovakia, South Korea, Spain...	clinicaltrials.gov
February 17, 2026	NCT07415044	LY4268989 in Adults With Moderately to Severely Active Ulcerative Colitis	Eli Lilly and Company	Phase 2	Recruiting	Ulcerative Colitis (UC), Ulcerative Colitis, Active Moderate, Ulcerative Colitis, Active Severe	1,431	Argentina, Brazil, Canada, China, Colombia, Croatia, Czechia, France, Greece...	clinicaltrials.gov
February 17, 2026	NCT07411950	EuroPainClinicsStudy IX ( EPCS IX )	EPC Education s.r.o.	Not applicable	Completed	Failed Back Surgery Syndrome, Lumbar Radiculopathy, Chronic Low Back Pain, Epidural Fibrosis	141	Slovakia	clinicaltrials.gov
February 10, 2026	NCT07400653	A Study to Learn About the Study Medicine (PF-08653944) in People With Obesity or Overweight and Type 2 Diabetes (T2D)	Pfizer	Phase 3	Active not recruiting	Obesity, Overweight and/or Obesity, Overweight, Diabetes, Type 2, Type 2 Diabetes	1,078	Argentina, Bulgaria, Canada, Czechia, Germany, Poland, Romania, Slovakia...	clinicaltrials.gov
January 29, 2026	NCT07374887	Impact of Snoezelen Intervention and Reminiscence Therapy on Seniors' Emotionality and Anxiety	Matej Bel University	Not applicable	Completed	Emotionality, Anxiety	55	Slovakia	clinicaltrials.gov
January 23, 2026	NCT07364318	Cognitive Function in Obstructive Sleep Apnea	Comenius University	Observational	Recruiting	OSA - Obstructive Sleep Apnea, Cognitive Functions	30	Slovakia	clinicaltrials.gov
January 22, 2026	NCT07359846	A Study to Investigate GB-0895 Adjunctive Therapy in Adults and Adolescents With Severe Uncontrolled Asthma (SOLAIRIA-2)	Generate Biomedicines	Phase 3	Recruiting	Severe Asthma	786	Argentina, Australia, Belgium, Estonia, France, Georgia, India, Ireland, Italy...	clinicaltrials.gov
January 22, 2026	NCT07357766	A Research Study to Compare Different Versions of Injectable CagriSema and Placebo in People With Excess Body Weight	Novo Nordisk A/S	Phase 3	Withdrawn	Overweight, Obesity	0	Bulgaria, Denmark, Greece, Hungary, Malaysia, Poland, Portugal, Romania...	clinicaltrials.gov
January 22, 2026	NCT07357740	A Research Study to Compare Two Different Versions of Injectable CagriSema in People With Type 2 Diabetes	Novo Nordisk A/S	Phase 2	Withdrawn	Diabetes Mellitus, Type 2	0	Denmark, Greece, Malaysia, Serbia, Slovakia, Spain, Thailand, United States	clinicaltrials.gov
January 21, 2026	NCT07355296	PODOMOUNT-Basket, a Study to Test Whether BI 764198 Helps Adults and Adolescents With Different Types of Kidney Disease	Boehringer Ingelheim	Phase 2	Recruiting	Proteinuric Kidney Diseases	132	Argentina, Australia, Belgium, Brazil, Canada, China, Croatia, Denmark, France...	clinicaltrials.gov
January 14, 2026	NCT07338929	Physical Performance Assessment in Kidney Transplant Evaluation	University Hospital, Martin	Observational	Recruiting	Frailty Syndrome	50	Slovakia	clinicaltrials.gov
January 14, 2026	NCT07338877	RenewDisc Trial: Endoscopic Discectomy and Autologous Stem Cell Therapy for Discogenic Low Back Pain	EPC Education s.r.o.	Observational	Enrolling by invitation	Discogenic Low Back Pain, Intervertebral Disc Degeneration, Lumbar Disc Disease, Chronic Low Back Pain	120	Slovakia	clinicaltrials.gov
January 13, 2026	NCT07338084	OpioidRedoxStudyII	EPC Education s.r.o.	Observational	Not yet recruiting	Oxidative Stress, Opioid Use	120	Slovakia	clinicaltrials.gov
January 12, 2026	NCT07332481	A Study of Enpatoran in Participants With Cutaneous Manifestations of Lupus With or Without Systemic Disease	EMD Serono Research & Development Institute, Inc.	Phase 3	Recruiting	Systemic Lupus Erythematosus (SLE), Cutaneous Lupus Erythematosus (CLE)	202	Australia, Belgium, Brazil, Bulgaria, China, France, Germany, Israel, Italy...	clinicaltrials.gov
January 8, 2026	NCT07326709	A Study to Investigate the Efficacy, Safety and Tolerability of Votoplam in Participants With Huntington's Disease	Novartis Pharmaceuticals	Phase 3	Recruiting	Huntington Disease	770	Argentina, Australia, Belgium, Bulgaria, Canada, China, Colombia, Czechia...	clinicaltrials.gov
January 7, 2026	NCT07323654	A Study of KT-621 Administered Orally to Adult Participants With Moderate to Severe Eosinophilic Asthma	Kymera Therapeutics, Inc.	Phase 2	Recruiting	Eosinophilic Asthma	264	Argentina, Austria, Belgium, Germany, Italy, Poland, Romania, Serbia, Slovakia...	clinicaltrials.gov
December 31, 2025	NCT07311850	Efficacy and Safety of MET097 Once-Weekly in People With Overweight or Obesity	Pfizer	Phase 3	Active not recruiting	Obesity and Overweight	3,578	Bulgaria, Canada, Czechia, Germany, Poland, Romania, Slovakia, Spain, United...	clinicaltrials.gov
December 24, 2025	NCT07301736	Therapeutic Equivalence of CHF5993 pMDI 100/6/12.5 µg HFA-152a in Subjects With Mild to Moderate Asthma	Chiesi Farmaceutici S.p.A.	Phase 2	Recruiting	Asthma	780	Argentina, Bosnia and Herzegovina, Bulgaria, Czechia, Germany, Hungary, Latvia...	clinicaltrials.gov
December 23, 2025	NCT07298252	Diagnostic Accuracy of Carebot AI MMG in Mammography Screening: Multicenter MRMC Study	Carebot s.r.o.	Observational	Completed	Breast Neoplasms, Breast Cancer Detection, Breast Cancer - Female, Breast Cancer Screening	222	Czechia, Slovakia	clinicaltrials.gov
December 17, 2025	NCT07290036	A Study to Learn if Bimekizumab Given in Different Ways is Safe and Moves Similarly Throughout the Body Over Time in Adults	UCB Biopharma SRL	Phase 1	Recruiting	Psoriatic Arthritis, Axial Spondyloarthritis	392	Bulgaria, Czechia, Germany, Poland, Slovakia, United States	clinicaltrials.gov
December 16, 2025	NCT07284472	Safety and Efficacy of EXV-802 and EXV-801 in the Treatment of Agitation in Alzheimer's Disease Dementia	Exciva GmbH	Phase 2/3	Recruiting	Agitation Associated With Alzheimer's Disease Dementia	300	Canada, Czechia, Germany, Italy, Poland, Slovakia, Spain, United Kingdom...	clinicaltrials.gov
December 15, 2025	NCT07282600	A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, and Type 2 Diabetes	Eli Lilly and Company	Phase 3	Recruiting	Overweight, Obesity	1,035	China, Czechia, Germany, India, Japan, Mexico, Poland, Puerto Rico, Slovakia...	clinicaltrials.gov
December 10, 2025	NCT07275541	Platelet Aggregation in the Diagnosis of Acute Graft Rejection	University Hospital, Martin	Observational	Recruiting	Platelet Aggregation, Kidney Transplant Rejection	60	Slovakia	clinicaltrials.gov
December 10, 2025	NCT07274462	DARA-MVI Study (Daratumumab for Microvascular Inflammation in Kidney Transplantation)	University Hospital, Martin	Phase 4	Active not recruiting	Microvascular Inflammation - MVI in Kindey Transplant Recipients	20	Slovakia	clinicaltrials.gov
December 5, 2025	NCT07268079	Validation of the VIRADIA App for Neurological and Cognitive Diagnostics in Virtual Reality	Gametherapy	Observational	Recruiting	Neurological Disorders, Cognitive Impairment, Motor Impairment, Neurodegenerative Diseases	200	Slovakia	clinicaltrials.gov
December 1, 2025	NCT07256392	Long-term Efficacy and Safety Extension (LTE) Study of Barzolvolimab in Participants With Chronic Spontaneous Urticaria	Celldex Therapeutics	Phase 3	Enrolling by invitation	Chronic Spontaneous Urticaria	1,370	Argentina, Australia, Belgium, Bulgaria, Canada, Chile, Colombia, Czechia...	clinicaltrials.gov
November 28, 2025	NCT07253285	A Research Study on How Well Cagrilintide and CagriSema Work in Children and Adolescents With Excess Body Weight	Novo Nordisk A/S	Phase 3	Recruiting	Overweight, Obesity	460	Australia, Austria, Belgium, Bulgaria, China, Colombia, Croatia, Denmark...	clinicaltrials.gov
November 24, 2025	NCT07244432	Post-ERCP Pancreatitis - Prophylactic Measures Implementation Study (PEP-PROMIS)	Branislav Kuncak	Observational	Completed	Pancreatitis, Acute, ERCP, Prophylaxis	1,135	Czechia, Slovakia	clinicaltrials.gov
November 21, 2025	NCT07241390	A Study of Orforglipron (LY3502970) on Cardiovascular Outcomes in Adults With Atherosclerotic Cardiovascular Disease and/or Chronic Kidney...	Eli Lilly and Company	Phase 3	Recruiting	Atherosclerosis Cardiovascular Disease, Chronic Kidney Disease	7,140	Argentina, Australia, Austria, Belgium, Brazil, Bulgaria, Canada, China...	clinicaltrials.gov
November 19, 2025	NCT07236281	Selenium Levels in Patients With Abdominal Aneurysm	Comenius University	Observational	Active not recruiting	Abdominal Aneurysm, Selenium Deficiency	40	Slovakia	clinicaltrials.gov
November 19, 2025	NCT07236268	Prevalence of HIV and Sexually Transmitted Infections in Migrant Communities in Slovakia	Comenius University	Observational	Completed	STIs, HIV, Rapid Detection	660	Slovakia	clinicaltrials.gov
November 6, 2025	NCT07225504	A Study to Evaluate the Efficacy and Safety of Remibrutinib in Secondary Progressive Multiple Sclerosis	Novartis Pharmaceuticals	Phase 3	Recruiting	Secondary Progressive Multiple Sclerosis (SPMS)	1,275	Argentina, Australia, Austria, Belgium, Brazil, Bulgaria, Canada, China...	clinicaltrials.gov
November 3, 2025	NCT07223593	Efficacy and Safety of Orforglipron in Participants With Peripheral Artery Disease	Eli Lilly and Company	Phase 3	Recruiting	Peripheral Arterial Disease	1,205	Argentina, Australia, Brazil, Canada, China, France, Greece, India, Israel...	clinicaltrials.gov
October 28, 2025	NCT07221734	Study to Compare Pharmacokinetics, Efficacy, Safety, and Immunogenicity of MB11 Versus EU-/US-Opdivo® in Subjects With Previously Untreated...	mAbxience Research S.L.	Phase 3	Recruiting	Advanced (Unresectable or Metastatic) Melanoma	632	Bosnia and Herzegovina, Brazil, Chile, Georgia, Greece, Italy, Peru, Portugal...	clinicaltrials.gov
October 24, 2025	NCT07220759	Weight Loss in People Living With Overweight or Obesity and Type 2 Diabetes Following Treatment With Cagrilintide	Novo Nordisk A/S	Phase 3	Active not recruiting	Overweight, Obesity, Type 2 Diabetes	330	Argentina, Canada, Croatia, Czechia, Hungary, Romania, Slovakia, South Korea...	clinicaltrials.gov
October 23, 2025	NCT07220252	Study to Assess Effects of Ublituximab in Pediatric Participants With Relapsing Forms of Multiple Sclerosis	TG Therapeutics, Inc.	Phase 2/3	Recruiting	Relapsing Multiple Sclerosis	240	Poland, Slovakia, United States	clinicaltrials.gov
October 23, 2025	NCT07220083	A Study to Find Out if BI 764198 Helps Adults and Adolescents With a Kidney Condition Called Focal Segmental Glomerulosclerosis (FSGS)	Boehringer Ingelheim	Phase 3	Recruiting	Focal Segmental Glomerulosclerosis	286	Argentina, Australia, Belgium, Brazil, Bulgaria, Canada, China, Croatia...	clinicaltrials.gov
October 22, 2025	NCT07219602	A Study to Evaluate the Effect of Obicetrapib/Ezetimibe 10 mg Fixed-Dose Combination or Obicetrapib 10 mg Daily on Top of...	NewAmsterdam Pharma	Phase 3	Active not recruiting	Lipidemia, Type 2 Diabetes (T2DM), Metabolic Syndrome (MetS)	300	Czechia, Netherlands, Slovakia, United States	clinicaltrials.gov
October 8, 2025	NCT07213271	Physical Exercise on Metabolic Health, Gut Microbiota, Physical Fitness, and Quality of Life in Obese Breast Cancer Survivors	Comenius University	Not applicable	Recruiting	Breast Cancer Females	40	Slovakia	clinicaltrials.gov
September 24, 2025	NCT07190222	Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic...	Sanofi	Phase 3	Recruiting	Chronic Obstructive Pulmonary Disease	942	Argentina, Australia, Brazil, Canada, Chile, China, Czechia, Germany, Greece...	clinicaltrials.gov
September 23, 2025	NCT07188844	An Open-Label Extension Study of Batoclimab in Adult Participants With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)	Immunovant Sciences GmbH	Phase 2	Terminated	Chronic Inflammatory Demyelinating Polyneuropathy	26	Argentina, Belgium, Brazil, Germany, Greece, Italy, Poland, Romania, Serbia...	clinicaltrials.gov
September 22, 2025	NCT07185009	A Maintenance Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Ulcerative...	Sanofi	Phase 3	Recruiting	Ulcerative Colitis	751	Argentina, Australia, Austria, Belgium, Bulgaria, Canada, Chile, China...	clinicaltrials.gov
September 22, 2025	NCT07184996	An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Ulcerative Colitis	Sanofi	Phase 3	Recruiting	Ulcerative Colitis	980	Argentina, Australia, Austria, Bulgaria, Canada, China, Czechia, France...	clinicaltrials.gov
September 22, 2025	NCT07184944	A Maintenance Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Crohn's Disease	Sanofi	Phase 3	Recruiting	Crohn's Disease	751	Australia, Austria, Belgium, Brazil, Bulgaria, Canada, Chile, China, Czechia...	clinicaltrials.gov
September 22, 2025	NCT07184931	An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Crohn's Disease	Sanofi	Phase 3	Recruiting	Crohn's Disease	980	Argentina, Australia, Austria, Belgium, Brazil, Bulgaria, Canada, Chile, China...	clinicaltrials.gov
September 18, 2025	NCT07181109	Zilebesiran in Patients With Hypertension Not Adequately Controlled and With Either Established Cardiovascular Disease or High Risk for...	Alnylam Pharmaceuticals	Phase 3	Recruiting	High Risk Cardiovascular Disease, Hypertension, High Cardiovascular Risk	11,000	Argentina, Australia, Austria, Belgium, Brazil, Bulgaria, Canada, Chile, China...	clinicaltrials.gov
September 10, 2025	NCT07165002	A Study of the Pharmacokinetics and Safety of LY3537031 in Participants With Normal Liver Function and With Mild, Moderate, or Severe Liver...	Eli Lilly and Company	Phase 1	Recruiting	Healthy, Hepatic Insufficiency	32	Hungary, New Zealand, Slovakia	clinicaltrials.gov
September 9, 2025	NCT07161700	An Open-Label Extension Study to Evaluate the Safety and Tolerability of SPT-300 (GlyphAllo) in Participants With Major Depressive...	Seaport Therapeutics	Phase 2	Enrolling by invitation	Major Depressive Disorder (MDD), Major Depressive Disorder With Anxious Distress	360	Bulgaria, Czechia, Germany, Hungary, Poland, Slovakia, United States	clinicaltrials.gov

Sponsors posting most

Sponsor	New trials	Latest
Comenius University	18	October 22, 2026
University Hospital, Martin	15	August 6, 2026
AstraZeneca	11	October 1, 2026
Novo Nordisk A/S	10	June 25, 2026
Eli Lilly and Company	9	February 17, 2026
Pfizer	9	February 10, 2026
Boehringer Ingelheim	7	November 4, 2026
Novartis Pharmaceuticals	7	June 2, 2026
EPC Education s.r.o.	5	April 30, 2026
Sanofi	5	September 24, 2025
Amgen	4	May 29, 2026
Janssen Research & Development, LLC	4	May 11, 2026
argenx	4	July 29, 2025
F.D. Roosevelt Teaching Hospital with Policlinic Banska Bystrica	3	April 30, 2026
Pleuran, s.r.o.	3	March 18, 2026
Bristol-Myers Squibb	3	July 21, 2025
Slovak Academy of Sciences	3	May 22, 2025
Spyre Therapeutics, Inc.	2	June 17, 2026
Merck Sharp & Dohme LLC	2	June 5, 2026
Diana Ďuricová	2	March 27, 2026

Conditions

Condition group	New trials	Latest
Obesity	16	August 25, 2026
Overweight	12	August 25, 2026
Diabetes Mellitus, Type 2	12	August 25, 2026
Colitis, Ulcerative	10	September 29, 2026
Breast Neoplasms	6	September 14, 2026
Crohn Disease	6	May 11, 2026
Cardiovascular Diseases	6	April 8, 2026
Depression	6	September 9, 2025
Renal Insufficiency, Chronic	5	August 6, 2026
Anxiety Disorders	5	March 27, 2026
Pulmonary Disease, Chronic Obstructive	5	September 24, 2025
Depressive Disorder, Major	5	September 9, 2025
Heart Failure	4	August 12, 2026
Prostatic Neoplasms	4	April 30, 2026
Diabetes Mellitus	4	April 16, 2026
Polyradiculoneuropathy, Chronic Inflammatory Demyelinating	4	September 23, 2025
Hypertension	4	September 18, 2025
Atherosclerosis	4	September 5, 2025
Colitis	3	September 29, 2026
Inflammatory Bowel Diseases	3	September 29, 2026
Motor Activity	3	September 28, 2026
Multiple Sclerosis	3	August 26, 2026
Atrial Fibrillation	3	August 19, 2026
Neoplasms	3	June 5, 2026
Fatigue	3	June 2, 2026

By phase

Phase	New trials	Latest
Phase 3	90	November 4, 2026
Not applicable	37	October 22, 2026
Observational	30	October 30, 2026
Phase 2	22	September 29, 2026
Phase 1	4	July 6, 2026
Phase 2/3	4	December 16, 2025
Phase 1/2	2	June 5, 2026
Early phase 1	1	August 6, 2026
Phase 4	1	December 10, 2025

Where the register publishes

U.S. government data; ClinicalTrials.gov terms of use. Studies are as their sponsors registered them on ClinicalTrials.gov, read through its API. Condition groups are the MeSH terms ClinicalTrials.gov assigns to each study's conditions; a study with several is in several groups. Sponsor class is the register's class of the lead sponsor. The central contact is in the full list only as the record prints it. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.